Authors
Latest:
Real-world data point to underutilization of germline, somatic testing in mCRPC"Certainly germline and somatic is recommended for all mCRPC patients to detect HR gene mutations, and consider options for PARP inhibitors,” says Neal Shore, MD, FACS.
Latest:
Chronic orchialgia: How to diagnose and treat the challenging conditionIn this interview, Parviz K. Kavoussi, MD, discusses his diagnostic work-up for patients who present with chronic testicular pain and describes conservative and surgical management approaches for the condition.
Latest:
Expert explains why automation is key to prior authorization reformAutomating prior authorization is an investment that every health care organization should consider. As the industry grapples with rapid regulatory shifts and acute staff shortages, a tailored automation strategy is key to enhancing patient care and improving operational efficiency.
Latest:
William Furuyama, MD, on community factors’ influence on urinary incontinence“Having a broader understanding of why someone might be experiencing the disease process or symptoms that they're coming in with is really meaningful and helpful, both to patients and to physicians,” says William Furuyama, MD.
Latest:
How data and technology facilitate health equity and boost the overall patient experience"Digital engagement technology, which can be seamlessly integrated into a health system or hospital's existing processes," writes Chelsea King Arthur.
Latest:
Alternative treatments and patient communication for genitourinary syndrome of menopauseKaryn S. Eilber, MD, discusses treatment of genitourinary syndrome of menopause.
Latest:
Addressing an unmet need: CELLEBRATE trial explores cell-based therapy for recurrent SUIThe CELLEBRATE trial is aiming to provide additional evidence to support the safety and efficacy of iltamiocel.
Latest:
Juan Andino, MD, highlights SUO session on telehealth in urology“Without Congressional action, all the progress that has been made—the new normal, so to speak—that patients, physicians, and providers alike have become used to, is at risk of potentially going back to pre-pandemic, 2019 levels,” says Juan J. Andino, MD, MBA.
Latest:
Vikram Narayan, MD, on the importance of tailoring patient communication“The key take home message of that study was that having assumptions about basic medical terminology that we think are simple may actually leave patients confused,” says Vikram M. Narayan, MD.
Latest:
Telehealth in urologic cancer: Lessons learned from the COVID-19 pandemic"The use of telemedicine is heavily dependent on supportive legislature," write Tracey L. Krupski, MD, and Jeunice Owens-Walton, MD.
Latest:
Pearls & Perspectives: Helen Bernie, DO, MPH, at AUA 2025Helen Bernie, DO, MPH, joins the show to discuss data from her Indiana University team from the floor at AUA 2025.
Latest:
Is a medical scribe right for your practice?“Regardless of the size of the practice, medical scribes are a valuable resource for health care providers, helping to streamline workflow and coordinate patient care,” writes Brian Hudson.
Latest:
Experts discuss review of the microbiome and bladder cancer"My biggest hope for people reading this review is to understand that there are some golden opportunities for research," says Laura Bukavina, MD, MPH, MSc.
Latest:
Diagnostic stewardship for urinary tract infection: A snapshot of the expert guidanceUrinary tract infections (UTIs) are among the most common human infections. But the urine culture, the cornerstone for laboratory diagnosis of UTI, is imperfect.
Latest:
Pearls & Perspectives: From Guidelines to Practice—Navigating the TRT Treatment Spectrum, with Alex Tatem, MDExplore the latest insights on testosterone therapy, its benefits, and practical applications from leading urologists in men's health.
Latest:
Combo of cabozantinib and pembrolizumab shows promise in frontline urothelial carcinomaResults from the phase 2 PemCab trial showed that the first-line combination elicited promising antitumor activity with tolerable toxicity in patients with advanced urothelial carcinoma, including those who were cisplatin ineligible.
Latest:
Mark Edney, MD, highlights pending telehealth legislation"The relaxation of the restrictions that started during COVID are critically important for continued access," says Mark T. Edney, MD.
Latest:
Pearls & Perspectives: Urology's role in GLP-1 RA treatments, with Hossein Sadeghi-Nejad, MD, and Nathalie Eid, BAThis episodes explores the evolving role of GLP-1 medications in testosterone management and their impact on male sexual health and fertility.
Latest:
FDA grants Regenerative Medicine Advanced Therapy designation to ALLO-316 for RCCThe RMAT designation is supported by interim data from the ongoing phase 1 TRAVERSE trial.
Latest:
Final Thoughts and Clinical Trials in NMIBCExperts share their concluding thoughts on the recent progress and future outlook for the treatment of non–muscle-invasive bladder cancer (NMIBC).
Latest:
Expert highlights program addressing disparities in prostate cancer careIn this interview, Mary-Ellen Taplin, MD, discusses disparities in prostate cancer care and a unique initiative aiming to alleviate those disparities.
Latest:
Scott Tagawa, MD, on the mechanism of action for 177Lu-TLX591 in mCRPC“If there's enough radiation, then the cells can't repair themselves and die because of the radiation,” says Scott T. Tagawa, MD, MS, FACP, FASCO.
Latest:
Data support use of 18F-PSMA-1007 PET/CT in prostate cancer“These findings support the use of 18F-PSMA-1007 PET/CT in the preoperative workflow of intermediate-and high-risk tumors,” said Nikhile Mookerji, MD.
Latest:
How to assemble a Thompson Retractor for midline transabdominal retroperitoneal surgeryThe patient presented with a large right renal mass who elected for right radical nephrectomy with possible inferior vena cava.
Latest:
Pearls & Perspectives: Martin Kathrins, MD, on MED3000 and learning from failed trialsKathrins discusses the intricacies of leading a clinical trial and why "negative" trials are important to informing care strategies.
Latest:
Joshua Heiman, MD, on phentermine plus topiramate for uric acid stone preventionJoshua M. Heiman, MD, details key findings from the POuND OUT study.
Latest:
Amar Kishan, MD, highlights ongoing research on reducing toxicity in SBRT"For the MIRAGE trial specifically, we're going to continue following patients and we'll look at [data at] 5 years as well," says Amar U. Kishan, MD.
Latest:
Diet and interstitial cystitis: A urologist’s view"There are some very strict IC diets that have been published, and I've had a handful of patients who have really found them helpful," says J. Quentin Clemens, MD, MSCI.
Latest:
Tips for successfully mentoring other physiciansHere are some helpful hints for launching your physician mentor-mentee relationship.
